Congratulations to Professor Sandra Cooper, Adjunct Research Scientist at CMRI, for developing a world-first database which could change the way genetic disease is diagnosed.
https://t.co/RaB4LAQsiK
Save the date! Sunday 9th October. NF Patients Community Day, Manchester
A day dedicated to NF patients & their families - learn about NF1, NF2 & Schwannomatosis, find out what support is available and meet others affected by NF.
Read more: https://t.co/2QYQm9oRZm
I am incredibly excited to announce the opening of a Phase 1 clinical trial testing a topical immunotherapy for adult cutaneous neurofibromas in NF1. @TheMountSinaiHospital in New York City. The NF Clinic at Mount Sinai.
https://t.co/NZiaWIemAL
I was already working as a clinical geneticist when I noticed that my 6 month old daughter had multiple cafe au lait spots. The realisation filled me with a sense of fear and uncertainty.
#EndNf#Nf1project#NF1
“Imagine becoming kind of famous for the ONE thing you dislike about yourself!”
That’s what happened to Lilly Simon when her rare genetic condition was mistaken for monkeypox in a TikTok video seen by millions. I spoke to her about the aftermath.
WATCH: https://t.co/PmSHvyjine
“There's no cure and living with it is just having to learn to deal with it. “
Lilly Simon is living with neurofibromatosis, a rare genetic disease that isn't typically in the headlines.
WATCH: https://t.co/PmSHvyjine
Be a part of our study into the genetic influencers on the development of neurofibromas in people with NF1. It might not change today but it might lead to a better future. #NF1Project#NF1#NFAwareness#EndNF
We now have participants registered from the USA, Canada, New Zealand, Australia and the UK which is exciting. Working hard to get information about the project to the NF community because 2,000 is a big target. Thank you for your help. #nf1project#NF1#NFAwareness#EndNF